BMJ Sexual & Reproductive Health

Papers
(The TQCC of BMJ Sexual & Reproductive Health is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Experiences of abortion in the UK Armed Forces: a cross-sectional survey26
Response to the letter: 'Sexual and reproductive health clinical consultations: preconception care' by Chingaraet al24
Understanding the experiences and needs of LGBTIQA+ individuals when accessing abortion care and pregnancy options counselling: a scoping review20
Reversal of medication abortion with progesterone: a systematic review17
Highlights from literature15
Why women choose at-home abortion via teleconsultation in France: drivers of telemedicine abortion during and beyond the COVID-19 pandemic14
Assessment of the impact of the COVID-19 pandemic on Sexual Assault Treatment Unit activity14
A systematic review and critical appraisal of menopause guidelines13
Contraception prescribing in England during the COVID-19 pandemic13
Three Delays Model applied to prevention of unsafe abortion in Ghana: a qualitative study13
The post-Roe potential of mifepristone and misoprostol in the United States12
Words matter: perforation… or transmural migration?12
Contraception in Person-Contraception Online (CiP-CO) cohort study11
Challenging misleading information about ‘abortion reversal’11
Views and experiences of long-acting reversible contraception among ethnic minorities in high-income countries: a systematic review of qualitative studies9
Going with the flow: the emergence of menstrual science9
Improving access to medicines for early medical abortion: learning from experiences of medicines licensing and service delivery9
Intrauterine devices: a summary of new guidance9
Vasectomy interest and awareness among patients and their partners in prenatal clinics in the United States8
Safeguarding and telemedical abortion services8
Correspondence on ‘Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding’ by DeLougheryet al8
Women should be able to obtain the progestogen-only pill from a pharmacist without a prescription8
Consequences of ‘medical exceptions’ in restrictive abortion legislation: caesarean scar ectopic pregnancy and beyond8
Japan initiates a groundbreaking market test of over-the-counter emergency contraceptive pills with pharmacies as a first access point8
Should patient-centred abortion care involve the offer of an ultrasound to all, including those who do not clinically require it?7
Improving postpregnancy contraceptive method choice and long-acting reversible contraception provision in Botswana: a quality improvement pilot7
Reflections and future directions for patient and public involvement and engagement (PPIE) in abortion research and service improvement7
Telemedicine as an alternative way to access abortion in Italy and characteristics of requests during the COVID-19 pandemic7
Reproductive and sexual health of Australian adolescents exposed to family and domestic violence7
Changes in male permanent contraception as partner access to long-acting reversible contraception (LARC) increases: an analysis of the National Survey for Family Growth, 2006–2010 versus 2017–20196
Oral contraception prescribing trends in Scottish general practices between 2016 and 20236
Health care professionals’ views on a new postpartum contraception audiovisual animation: a survey6
Time trends in contraceptive prescribing in UK primary care 2000–2018: a repeated cross-sectional study6
COVID-19 pandemic exacerbation of disparities in access to public abortion services in Mexico6
Correction:Accessing abortion outside jurisdiction following legalisation of abortion in the Republic of Ireland6
Highlights from the literature6
Predictors of post-vasectomy semen analysis completion6
Nurse practitioner medication abortion providers in Canada: results from a national survey6
Correction:Should emergency contraception be a general sales medicine?6
Highlights from the literature6
Client perspectives on choice of abortion method in England and Wales5
Could routine pregnancy self-testing facilitate earlier recognition of unintended pregnancy? A feasibility study among South African women5
Understanding women’s views of and preferences for accessing postpartum contraception: a qualitative evidence synthesis5
Termination of pregnancy services: a year in review in a tertiary maternity hospital5
Blood clots, COVID-19 vaccines and the contraceptive pill: are we heading for a repeat of the 1995 pill scare?5
Contraceptive use and pregnancy planning in Britain during the first year of the COVID-19 pandemic: findings from a large, quasi-representative survey (Natsal-COVID)5
Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis5
Foregrounding pain in self-managed early medication abortion: a qualitative study5
Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial5
Drug sellers’ knowledge and practices, and client perspectives after an intervention to improve the quality of safe abortion care outside of formal clinics in Nigeria5
Attitudes towards the regulation and provision of abortion among healthcare professionals in Britain: cross-sectional survey data from the SACHA Study5
Sexual well-being among young people in remote rural island communities in Scotland: a mixed methods study5
Scaling-up post-pregnancy family planning services: experiences and challenges from Afghanistan5
Celebrating 50 years of our Journal4
Defining counselling in contraceptive information and services: outcomes from an expert think tank4
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption4
Women’s experiences of the consenting process for pregnancy remains disposal following early miscarriage4
Pharmacy dispensing of abortion pills in Ghana: experiences of pharmacy workers and users4
Desire to Avoid Pregnancy scale: clinical considerations and comparison with other questions about pregnancy preferences4
‘Direct booking’ for intrauterine contraception appointments: a better way of working?4
Contraceptive efficacy and global licensing of 52 mg levonorgestrel intrauterine devices: does a Mirena last longer in New York than York?4
Intendedness of pregnancies and preconception contraceptive use in women of Swedish and non-European origins seeking emergency care in early pregnancy4
Expectations and experiences of pain during medical abortion at home: a secondary, mixed-methods analysis of a patient survey in England and Wales3
Provision of care to diverse populations: results from the 2019 Canadian Abortion Provider Survey3
Unexpected pregnancy with intrauterine contraception in situ3
Lifestyle risk reduction engagement during interconception: a qualitative descriptive study of women’s preferences3
Training abortion doulas in Northern Ireland: lessons from a COVID-19 context3
Shifting discourses, changing interests? How the language of sexual and reproductive health has evolved in the past 50 years3
Influence of the COVID-19 pandemic on births and induced abortions in Southern Sweden: a register-based study3
Reasons for using telemedicine medical abortion in Mexico and Chile3
Involving young people in sexual health research and service improvement: conceptual analysis of patient and public involvement (PPI) in three projects3
Contraception after childbirth in the UK: beyond the COVID-19 pandemic3
Understanding women from ethnic minorities’ perspectives about contraception in the UK: a qualitative study using a participatory action research approach with community research link workers3
Patient experiences of undergoing abortion with and without an ultrasound scan in Britain3
Venus3
Abortion care: ensuring excellence, promoting wellbeing and improving training3
Highlights from the literature3
Australian women’s experiences and perceptions of interconception care: a qualitative descriptive study3
Time to treat the climate and nature crisis as one indivisible global health emergency3
Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study3
Evaluation of the psychometric properties of the Reproductive Autonomy Scale for use in the UK3
Expanding insurance coverage to include newly available over-the-counter contraceptives in the United States3
Evaluating the effectiveness of a tailored online educational video on the contraceptive knowledge and decision making of young women from culturally and linguistically diverse backgrounds: findings f3
Call for emergency action to limit global temperature increases, restore biodiversity and protect health3
‘Making abortion safe’: abortion and post-abortion care providers’ experiences of stigma in Rwanda, Zimbabwe, Sierra Leone and Nigeria3
Analysing MyOptions: experiences of Ireland’s abortion information and support service3
French women’s experiences and opinions with in-country versus cross-border abortion travel: a mixed-methods paper3
Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding3
0.065639972686768